International Journal of Cancer Management

Published by: Kowsar

Salivary Lipid Peroxidation and Antioxidant Status in the Patients with Papillary Thyroid Carcinoma: A Case-Control Study

Samaneh Famil Sagharchian 1 , Mahdi Hedayati 2 , Faranak Kazerouni 1 , * , Ali Rahimipour 1 and Mehrnoosh Shanaki 1
Authors Information
1 Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Cellular and Molecular Research Center, Research Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: March 2018, 11 (3); e9941
  • Published Online: March 25, 2018
  • Article Type: Research Article
  • Received: January 7, 2017
  • Revised: May 20, 2017
  • Accepted: March 6, 2018
  • DOI: 10.5812/ijcm.9941

To Cite: Famil Sagharchian S, Hedayati M, Kazerouni F, Rahimipour A, Shanaki M. et al. Salivary Lipid Peroxidation and Antioxidant Status in the Patients with Papillary Thyroid Carcinoma: A Case-Control Study, Int J Cancer Manag. 2018 ;11(3):e9941. doi: 10.5812/ijcm.9941.

Abstract
© 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Iftikhar A, Naseeb AK, Khwaja A, Mati H, Karim K, Hameeda N. Patterns of differentiated thyroid cancer in Baluchistan Province of Pakistan: some initial observations. Med J Malaysia. 2011;66(4):322-5. [PubMed: 22299551].
  • 2. Cossu A, Budroni M, Paliogiannis P, Palmieri G, Scognamillo F, Cesaraccio R, et al. Epidemiology of thyroid cancer in an area of epidemic thyroid goiter. J Cancer Epidemiol. 2013;2013:584768. doi: 10.1155/2013/584768. [PubMed: 23533411].
  • 3. Nozhat Z, Hedayati M, Azizi F. Thyroid Cancer Epidemic: A Peril or an Alarm? Int J Endocrinol Metab. 2015;13(4). e28491. doi: 10.5812/ijem.28491. [PubMed: 26633981].
  • 4. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009;20(5):525-31. doi: 10.1007/s10552-008-9260-4. [PubMed: 19016336].
  • 5. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-7. doi: 10.1001/jama.295.18.2164. [PubMed: 16684987].
  • 6. Leenhardt L, Grosclaude P, Cherie-Challine L, Thyroid Cancer C. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid. 2004;14(12):1056-60. doi: 10.1089/thy.2004.14.1056. [PubMed: 15650358].
  • 7. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer. 1998;83(12):2638-48. [PubMed: 9874472].
  • 8. Hosseini-Zijoud SM, Ebadi SA, Goodarzi MT, Hedayati M, Abbasalipourkabir R, Mahjoob MP, et al. Lipid Peroxidation and Antioxidant Status in Patients with Medullary Thyroid Carcinoma: A Case-Control Study. J Clin Diagn Res. 2016;10(2):BC04-7. doi: 10.7860/JCDR/2016/17854.7202. [PubMed: 27042443].
  • 9. Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S, et al. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cir Bras. 2008;23(6):551-4. [PubMed: 19030755].
  • 10. Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW. Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer. 2011;18(6):773-82. doi: 10.1530/ERC-11-0230. [PubMed: 22002574].
  • 11. Mussavira S, Dharmalingam M, Omana Sukumaran B. Salivary glucose and antioxidant defense markers in type II diabetes mellitus. Turk J Med Sci. 2015;45(1):141-7. [PubMed: 25790543].
  • 12. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer. 2007;109(1):54-9. doi: 10.1002/cncr.22386. [PubMed: 17099862].
  • 13. Sadani GR, Nadkarni GD. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett. 1996;109(1-2):231-5. [PubMed: 9020926].
  • 14. Dumitrescu C, Belgun M, Olinescu R, Lianu L, Bartoc C. Effect of vitamin C administration on the ratio between the pro-and antioxidative factors. Roman J Endocrinol. 1993;31(1-2):81-4.
  • 15. Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, et al. A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res. 2010;138(1-3):107-15. doi: 10.1007/s12011-010-8625-1. [PubMed: 20204550].
  • 16. Erdamar H, Cimen B, Gulcemal H, Saraymen R, Yerer B, Demirci H. Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma. Clin Biochem. 2010;43(7-8):650-4. doi: 10.1016/j.clinbiochem.2010.02.005. [PubMed: 20171198].
  • 17. Sener DE, Gonenc A, Akinci M, Torun M. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct. 2007;25(4):377-82. doi: 10.1002/cbf.1308. [PubMed: 16447143].
  • 18. Totan A, Miricescu D, Parlatescu I, Mohora M, Greabu M. Possible salivary and serum biomarkers for oral lichen planus. Biotech Histochem. 2015;90(7):552-8. doi: 10.3109/10520295.2015.1016115. [PubMed: 25839238].
  • 19. Vlkova B, Stanko P, Minarik G, Tothova L, Szemes T, Banasova L, et al. Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol. 2012;57(12):1651-6. doi: 10.1016/j.archoralbio.2012.09.003. [PubMed: 23092610].
  • 20. Miricescu D, Greabu M, Totan A, Didilescu A, Rădulescu R. The antioxidant potential of saliva: clinical significance in oral diseases. Molecules. 2011;4(5).
  • 21. Sadati Zarrini A, Moslemi D, Parsian H, Vessal M, Mosapour A, Shirkhani Kelagari Z. The status of antioxidants, malondialdehyde and some trace elements in serum of patients with breast cancer. Caspian J Intern Med. 2016;7(1):31-6. [PubMed: 26958330].
  • 22. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimuro K, et al. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res. 1997;29(7):351-4. [PubMed: 9288568].
  • 23. Kosova F, Cetin B, Akinci M, Aslan S, Ari Z, Sepici A, et al. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer. Ann Surg Oncol. 2007;14(9):2616-20. doi: 10.1245/s10434-007-9425-5. [PubMed: 17564752].
  • 24. Onder C, Kurgan S, Altingoz SM, Bagis N, Uyanik M, Serdar MA, et al. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress. Clin Oral Investig. 2017;21(6):1961-9. doi: 10.1007/s00784-016-1984-z. [PubMed: 27807715].
  • 25. Bosch JA. The use of saliva markers in psychobiology: mechanisms and methods. Monogr Oral Sci. 2014;24:99-108. doi: 10.1159/000358864. [PubMed: 24862598].
  • 26. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011;57(5):675-87. doi: 10.1373/clinchem.2010.153767. [PubMed: 21383043].

Altmetric:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Comments